IBEX (IBEX) Q4 2020 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2020 earnings summary
5 Nov, 2026Executive summary
FY20 revenue rose 10% YoY to $405.1m; continuing-operations net income was $7.8m versus a $4.5m loss in FY19. Adjusted EBITDA rose 49% to $54.1m.
Resilience through COVID-19 included shifting more than 10,000 employees to work-from-home while keeping over 98% of the workforce working; client retention was 100%.
The business ended FY20 with more than 23,000 employees, 30 branded centers across seven geographies, and 24 new client wins.
Financial highlights
Revenue was $405.1m, up $36.8m or 10.0% YoY; new-client onboarding contributed $12.3m and continuing ramps from FY19 wins added $37.3m, partly offset by a $13.7m mature-sector wind-down.
Operating income increased to $19.5m from $6.8m; operating margin improved to 4.8% from 1.8%, supported by utilization, offshore/nearshore mix and cost discipline.
Continuing-operations net income was $7.8m versus a $4.5m loss in FY19; total net income was $7.8m versus $11.0m, which included $15.5m from discontinued operations.
COVID-related one-time expenses were $6.1m net of client reimbursements; other operating costs also included $3.5m of higher Amazon warrant fair-value expense and $0.7m of intangible impairment.
Outlook and guidance
Management expected FY20 new-client wins to ramp over multiple years; historically, wins generated 2.5x–4.5x revenue in the second and third engagement years.
FY21 priorities included winning New Economy and digitally transforming blue-chip clients, expanding nearshore and Philippines markets, investing in technology and sales, and targeted M&A in technology and key verticals.
Management expected IPO proceeds, cash, operating cash generation and revolving facilities to cover liquidity needs for at least 12 months; IPO funds were earmarked for facility expansion, support systems and/or high-interest debt repayment.
Latest events from IBEX
- AI wins and HealthTech growth add momentum to double-digit expansion and margin gains.IBEX
RBC Global Technology, Internet, Media and Telecommunications Conference - D.F. King will support proxy solicitation ahead of the Dec. 10, 2026 annual meeting.IBEX
Proxy filing - Record Q1 growth and AI momentum underpin higher FY27 revenue and EBITDA guidance.IBEX
Q1 2027 - Record FY26 results and AI expansion accompany eight shareholder votes.IBEX
Proxy filing - Eight shareholder votes pair strong FY2026 growth with governance and equity-plan changes.IBEX
Proxy filing - Double-digit growth, expanding margins, and AI-driven innovation fuel a positive outlook.IBEX
Small-Cap Virtual Conference - Record revenue and earnings growth, with strong 2027 outlook driven by AI solutions.IBEX
Q4 2026 - Record revenue, raised guidance, and new AI partnership drive strong growth and profitability.IBEX
Q3 2026 - Record revenue, margin expansion, and raised guidance highlight strong Q2 and AI-driven growth.IBEX
Q2 2025